Abbott Laboratories (ABT)

Abbott Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	6,896	10,170	10,249	7,148	4,140
Short-Term Investments	383	0	0	0	0
Cash & Cash Equivalents	7,279	10,170	10,249	7,148	4,140
Cash Growth	-28.43%	-0.77%	43.38%	72.66%	1.32%
Receivables	6,565	6,218	6,487	6,414	5,425
Inventory	6,570	6,173	5,157	5,012	4,316
Other Current Assets	2,256	2,663	2,346	1,867	1,786
Total Current Assets	22,670	25,224	24,239	20,441	15,667
Property, Plant & Equipment	10,154	9,162	8,959	9,029	8,038
Long-Term Investments	799	766	816	821	883
Goodwill and Intangibles	32,494	33,253	35,970	38,528	40,220
Other Long-Term Assets	7,097	6,033	5,212	3,729	3,079
Total Long-Term Assets	50,544	49,214	50,957	52,107	52,220
Total Assets	73,214	74,438	75,196	72,548	67,887
Accounts Payable	4,295	4,607	4,408	3,946	3,252
Current Debt	1,080	2,251	754	220	1,478
Other Current Liabilities	8,466	8,631	7,943	7,741	6,133
Total Current Liabilities	13,841	15,489	13,105	11,907	10,863
Long-Term Debt	13,599	14,522	17,296	18,527	16,661
Other Long-Term Liabilities	6,947	7,522	8,771	9,111	9,062
Total Long-Term Liabilities	20,546	22,044	26,067	27,638	25,723
Total Liabilities	34,387	37,533	39,172	39,545	36,586
Total Debt	14,679	16,773	18,050	18,747	18,139
Debt Growth	-12.48%	-7.07%	-3.72%	3.35%	-7.29%
Retained Earnings	37,554	35,257	31,528	27,627	25,847
Comprehensive Income	-7,839	-8,051	-8,374	-8,946	-8,465
Shareholders' Equity	38,827	36,905	36,024	33,003	31,301
Net Cash / Debt	-7,400	-6,603	-7,801	-11,599	-13,999
Net Cash Per Share	-4.23	-3.74	-4.36	-6.49	-7.86
Working Capital	8,829	9,735	11,134	8,534	4,804
Book Value Per Share	22.31	21.05	20.30	18.61	17.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).